London Stock Exchange – Biogen : Evaluation of aducanumab safety in early Alzheimer’s disease at AD/PD
London Stock Exchange - Biogen : Evaluation of aducanumab safety in early Alzheimer's disease at AD/PD ...
Home » aducanumab
London Stock Exchange - Biogen : Evaluation of aducanumab safety in early Alzheimer's disease at AD/PD ...